RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Shyam Reddy to Transcription Factors

This is a "connection" page, showing publications Shyam Reddy has written about Transcription Factors.
Connection Strength

1.590
  1. Zou JP, Hirose Y, Siddique H, Rao VN, Reddy ES. Structure and expression of variant BRCA2a lacking the transactivation domain. Oncol Rep. 1999 Mar-Apr; 6(2):437-40.
    View in: PubMed
    Score: 0.121
  2. Siddique H, Zou JP, Rao VN, Reddy ES. The BRCA2 is a histone acetyltransferase. Oncogene. 1998 Apr 30; 16(17):2283-5.
    View in: PubMed
    Score: 0.114
  3. Yi H, Fujimura Y, Ouchida M, Prasad DD, Rao VN, Reddy ES. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Oncogene. 1997 Mar 20; 14(11):1259-68.
    View in: PubMed
    Score: 0.106
  4. Rao VN, Shao N, Ahmad M, Reddy ES. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene. 1996 Feb 01; 12(3):523-8.
    View in: PubMed
    Score: 0.098
  5. Fujimura Y, Ohno T, Siddique H, Lee L, Rao VN, Reddy ES. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene. 1996 Jan 04; 12(1):159-67.
    View in: PubMed
    Score: 0.097
  6. Rao VN, Reddy ES. elk-1 proteins interact with MAP kinases. Oncogene. 1994 Jul; 9(7):1855-60.
    View in: PubMed
    Score: 0.088
  7. Prasad DD, Rao VN, Lee L, Reddy ES. Differentially spliced erg-3 product functions as a transcriptional activator. Oncogene. 1994 Feb; 9(2):669-73.
    View in: PubMed
    Score: 0.085
  8. Rao VN, Reddy ES. Elk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase. Cancer Res. 1993 Aug 01; 53(15):3449-54.
    View in: PubMed
    Score: 0.082
  9. Siddique HR, Rao VN, Lee L, Reddy ES. Characterization of the DNA binding and transcriptional activation domains of the erg protein. Oncogene. 1993 Jul; 8(7):1751-5.
    View in: PubMed
    Score: 0.082
  10. Rao VN, Reddy ES. Delta elk-1, a variant of elk-1, fails to interact with the serum response factor and binds to DNA with modulated specificity. Cancer Res. 1993 Jan 15; 53(2):215-20.
    View in: PubMed
    Score: 0.079
  11. Rao VN, Reddy ES. elk-1 domains responsible for autonomous DNA binding, SRE:SRF interaction and negative regulation of DNA binding. Oncogene. 1992 Nov; 7(11):2335-40.
    View in: PubMed
    Score: 0.078
  12. Dudek H, Tantravahi RV, Rao VN, Reddy ES, Reddy EP. Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter. Proc Natl Acad Sci U S A. 1992 Feb 15; 89(4):1291-5.
    View in: PubMed
    Score: 0.074
  13. Reddy ES, Rao VN. erg, an ets-related gene, codes for sequence-specific transcriptional activators. Oncogene. 1991 Dec; 6(12):2285-9.
    View in: PubMed
    Score: 0.073
  14. Reddy ES, Rao VN. Localization and modulation of the DNA-binding activity of the human c-ets-1 protooncogene. Cancer Res. 1990 Aug 15; 50(16):5013-6.
    View in: PubMed
    Score: 0.067
  15. Rao VN, Huebner K, Isobe M, ar-Rushdi A, Croce CM, Reddy ES. elk, tissue-specific ets-related genes on chromosomes X and 14 near translocation breakpoints. Science. 1989 Apr 07; 244(4900):66-70.
    View in: PubMed
    Score: 0.061
  16. Reddy ES, Rao VN. Structure, expression and alternative splicing of the human c-ets-1 proto-oncogene. Oncogene Res. 1988; 3(3):239-46.
    View in: PubMed
    Score: 0.056
  17. Reddy ES, Rao VN, Papas TS. The erg gene: a human gene related to the ets oncogene. Proc Natl Acad Sci U S A. 1987 Sep; 84(17):6131-5.
    View in: PubMed
    Score: 0.055
  18. Fujimura Y, Siddique H, Lee L, Rao VN, Reddy ES. EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function. Oncogene. 2001 Oct 11; 20(46):6653-9.
    View in: PubMed
    Score: 0.036
  19. Chai Y, Chipitsyna G, Cui J, Liao B, Liu S, Aysola K, Yezdani M, Reddy ES, Rao VN. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells. Oncogene. 2001 Mar 15; 20(11):1357-67.
    View in: PubMed
    Score: 0.035
  20. Shao N, Chai Y, Cui JQ, Wang N, Aysola K, Reddy ES, Rao VN. Induction of apoptosis by Elk-1 and deltaElk-1 proteins. Oncogene. 1998 Jul 30; 17(4):527-32.
    View in: PubMed
    Score: 0.029
  21. Cui JQ, Shao N, Chai Y, Wang H, Reddy ES, Rao VN. BRCA1 splice variants BRCA1a and BRCA1b associate with CBP co-activator. Oncol Rep. 1998 May-Jun; 5(3):591-5.
    View in: PubMed
    Score: 0.029
  22. Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene. 1997 Jul 10; 15(2):143-57.
    View in: PubMed
    Score: 0.027
  23. Cui JQ, Wang H, Reddy ES, Rao VN. Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b. Oncol Rep. 1998 May-Jun; 5(3):585-9.
    View in: PubMed
    Score: 0.007
  24. Bhattacharya G, Lee L, Reddy ES, Rao VN. Transcriptional activation domains of elk-1, delta elk-1 and SAP-1 proteins. Oncogene. 1993 Dec; 8(12):3459-64.
    View in: PubMed
    Score: 0.005
  25. Hipskind RA, Rao VN, Mueller CG, Reddy ES, Nordheim A. Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature. 1991 Dec 19-26; 354(6354):531-4.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support